Eggenstein-Leopoldshafen, Germany

Alexandra Matzke-Ogi

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Amcure Gmbh, Ruprecht-Karls-Universität. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandra Matzke-Ogi. Retrieved from https://idiyas.com/inventor/alexandra-matzke-ogi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexandra Matzke-Ogi: Innovator in Cancer Treatment

Introduction

Alexandra Matzke-Ogi is a prominent inventor based in Eggenstein-Leopoldshafen, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic compounds. Her work focuses on utilizing cyclic peptides to address various forms of cancer and related diseases.

Latest Patents

Matzke-Ogi holds a patent for "CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases." This invention encompasses compounds, pharmaceutical compositions, and methods aimed at treating different types of cancer and diseases associated with angiogenesis. The patent highlights her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout her career, Matzke-Ogi has worked with notable organizations, including Amcure GmbH and Ruprecht-Karls-Universität. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Matzke-Ogi has collaborated with esteemed colleagues such as Véronique Orian-Rousseau and Uwe Haberkorn. These partnerships have further enriched her research and expanded the impact of her work in cancer treatment.

Conclusion

Alexandra Matzke-Ogi is a trailblazer in the field of cancer research, with a focus on innovative treatments using cyclic peptides. Her contributions are paving the way for new therapeutic options and enhancing the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…